GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹34.83 | ₹36.05 | ₹100.04 | ₹21.14 | ₹5.50 |
What is the latest Earnings Per Share (EPS) of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹34.83 |
| Mar2024 | ₹36.05 |
| Mar2023 | ₹100.04 |
| Mar2022 | ₹21.14 |
| Mar2021 | ₹5.50 |
How is Earnings Per Share (EPS) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹34.83 | -3.38 | |
| Mar2024 | ₹36.05 | -63.96 | |
| Mar2023 | ₹100.04 | 373.23 | |
| Mar2022 | ₹21.14 | 284.36 | |
| Mar2021 | ₹5.50 | - | |
Compare Earnings Per Share (EPS) of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,717.6 Cr | -0.6% | 3.2% | -0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -0.6% |
3.2% |
-0.1% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses